These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18625714)

  • 1. Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression.
    Singh PK; Behrens ME; Eggers JP; Cerny RL; Bailey JM; Shanmugam K; Gendler SJ; Bennett EP; Hollingsworth MA
    J Biol Chem; 2008 Oct; 283(40):26985-95. PubMed ID: 18625714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.
    Bozkaya G; Korhan P; Cokaklı M; Erdal E; Sağol O; Karademir S; Korch C; Atabey N
    Mol Cancer; 2012 Sep; 11():64. PubMed ID: 22962849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived growth factor receptor beta-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells.
    Singh PK; Wen Y; Swanson BJ; Shanmugam K; Kazlauskas A; Cerny RL; Gendler SJ; Hollingsworth MA
    Cancer Res; 2007 Jun; 67(11):5201-10. PubMed ID: 17545600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells.
    Matteucci E; Bendinelli P; Desiderio MA
    Carcinogenesis; 2009 Jun; 30(6):937-45. PubMed ID: 19357348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ets domain transcription factor PE1 suppresses human interstitial collagenase promoter activity by antagonizing protein-DNA interactions at a critical AP1 element.
    Bidder M; Loewy AP; Latifi T; Newberry EP; Ferguson G; Willis DM; Towler DA
    Biochemistry; 2000 Aug; 39(30):8917-28. PubMed ID: 10913304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
    Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
    Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor differently influences Met-E-cadherin phosphorylation and downstream signaling pathway in two models of breast cells.
    Matteucci E; Ridolfi E; Desiderio MA
    Cell Mol Life Sci; 2006 Sep; 63(17):2016-26. PubMed ID: 16909210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity.
    Ye J; Wei X; Shang Y; Pan Q; Yang M; Tian Y; He Y; Peng Z; Chen L; Chen W; Wang R
    Oncogene; 2017 Nov; 36(46):6391-6407. PubMed ID: 28745318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosines in the MUC1 cytoplasmic tail modulate transcription via the extracellular signal-regulated kinase 1/2 and nuclear factor-kappaB pathways.
    Thompson EJ; Shanmugam K; Hattrup CL; Kotlarczyk KL; Gutierrez A; Bradley JM; Mukherjee P; Gendler SJ
    Mol Cancer Res; 2006 Jul; 4(7):489-97. PubMed ID: 16849524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF.
    Behrens ME; Grandgenett PM; Bailey JM; Singh PK; Yi CH; Yu F; Hollingsworth MA
    Oncogene; 2010 Oct; 29(42):5667-77. PubMed ID: 20697347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SPRY domain-containing SOCS box protein 1 (SSB-1) interacts with MET and enhances the hepatocyte growth factor-induced Erk-Elk-1-serum response element pathway.
    Wang D; Li Z; Messing EM; Wu G
    J Biol Chem; 2005 Apr; 280(16):16393-401. PubMed ID: 15713673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line.
    Ozaki I; Zhao G; Mizuta T; Ogawa Y; Hara T; Kajihara S; Hisatomi A; Sakai T; Yamamoto K
    J Hepatol; 2002 Feb; 36(2):169-78. PubMed ID: 11830328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.
    Shintani T; Kusuhara Y; Daizumoto K; Dondoo TO; Yamamoto H; Mori H; Fukawa T; Nakatsuji H; Fukumori T; Takahashi M; Kanayama H
    Urology; 2017 Mar; 101():169.e7-169.e13. PubMed ID: 28013036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes.
    Monga SP; Mars WM; Pediaditakis P; Bell A; Mulé K; Bowen WC; Wang X; Zarnegar R; Michalopoulos GK
    Cancer Res; 2002 Apr; 62(7):2064-71. PubMed ID: 11929826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering.
    Tulasne D; Paumelle R; Weidner KM; Vandenbunder B; Fafeur V
    Mol Biol Cell; 1999 Mar; 10(3):551-65. PubMed ID: 10069803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 down-regulates matrix metalloproteinase-1 by targeting the communications between AP-1 and the basal transcription complex.
    Sun Y; Zeng XR; Wenger L; Firestein GS; Cheung HS
    J Cell Biochem; 2004 May; 92(2):258-69. PubMed ID: 15108353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Met-induced JNK activation is mediated by the adapter protein Crk and correlates with the Gab1 - Crk signaling complex formation.
    Garcia-Guzman M; Dolfi F; Zeh K; Vuori K
    Oncogene; 1999 Dec; 18(54):7775-86. PubMed ID: 10618718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC1 drives c-Met-dependent migration and scattering.
    Horm TM; Bitler BG; Broka DM; Louderbough JM; Schroeder JA
    Mol Cancer Res; 2012 Dec; 10(12):1544-54. PubMed ID: 23193156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells.
    Mori Y; Akita K; Tanida S; Ishida A; Toda M; Inoue M; Yashiro M; Sawada T; Hirakawa K; Nakada H
    J Biol Chem; 2014 Dec; 289(51):35193-204. PubMed ID: 25371209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients.
    Lee WY; Chen HH; Chow NH; Su WC; Lin PW; Guo HR
    Clin Cancer Res; 2005 Mar; 11(6):2222-8. PubMed ID: 15788670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.